- pre-open

Other headlines for [AET]

• UNH Today 07:40am
  UnitedHealth Group Inc Guides 2009 Commercial Enrollment down 1-1.5M y/y; Full year decline of 450-800K commercial risk based members- Sees 2009 Medicare advantage enrollemnt up 10-135K y/y - Sees 2009 Medicade more...
  
• Yesterday 08:15am
  Merrill cutting price targets in numerous managed care names- HUM price target cut to $40 from $48 - MGLN price target cut to $44 from $47 - WLP price target remains $48 - CI price target remains more...
  
• AET 11/19/2008 12:32pm
  Aetna Inc CEO: We are definitely taking market share, growing across all segments
  
• AET 11/12/2008 04:15pm
  Aetna Inc Names Lonny Reisman, M.D. as Chief Medical Officer- Reisman is the CEO and co-founder of ActiveHealth Management, now an Aetna subsidiary. He will join Aetna's management executive committee.
  
• 11/12/2008 10:24am
  Moody's: US Health Insurance sector outlook turns negative
  

Healthcare sector headlines

• NPSP Today 08:50am
  NPS Pharmaceuticals Inc. Update: Initiates Phase 3 'STEPS' Study to Confirm GATTEX Reduces Parenteral Nutrition Dependence in Short Bowel Syndrome- Patient enrollment has begun in a Phase 3 registrational study to confirm more...
  
• OCLS Today 08:48am
  Oculus Innovative Sciences Update: Signs development agreement with Bayer Taiwan for Microcyn tech in Taiwanese animal market- As part of the agreement, Bayer Taiwan Co. Ltd. will be responsible for securing Taiwanese more...
  
• TPTX Today 08:47am
  TorreyPines Therapeutics Update: Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia- Announced positive results from a 26 patient Phase II trial evaluating three doses of NGX267 as more...
  
• CUR Today 08:02am
  Neuralstem Inc Collaborates with Hospital in Taiwan to Develop Additional ALS Stem Cell Clinical Trials- The collaboration will focus on Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease) with Dr. more...
  
• SVA Today 08:01am
  Sinovac Biotech Announces share buyback of up to $2M (5.5% of market cap)